Cipla close to committing $1 billion advance for Moderna COVID-19 booster vaccine in India
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India
United Kingdom Zydus Cadila Us Countermeasures Injury Compensation Program Liberalised Pricing Accelerated National Injury Compensation Program
Source: businesstoday.in